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Smoking is the leading preventable cause of illness and death in our soci-
ety. Tobacco use is responsible for approximately 3 million deaths world-
wide [1] with over 430,000 in the United States alone [2]. To put these
ﬁgures in perspective, more lives are lost to tobacco than those caused by
alcohol, recreational drugs, ﬁres, automobile accidents, suicides, homicides
and AIDS combined. Currently, more than one in ﬁve adult deaths in the
United States is attributable to tobacco [2]. It has been projected that one
in three adult deaths will be attributable to tobacco use worldwide by
2020 [3]. Despite the known health hazards of tobacco use, smoking remains
highly prevalent, with an estimated 46.5 million adults, or nearly 24% of US
adults over 18, currently smoking cigarettes [4]. The economic burden of
tobacco related health care is enormous. An estimated $50 to $73 billion are
spent on direct excess medical costs attributable to smoking annually, with
an additional estimated $50 billion in indirect attributable costs [5,6]. How-
ever, these ﬁgures may grossly underestimate the total cost to the society,
since they do not include loss of lives and property from smoking related
ﬁres, perinatal care for low birth weight infants of mothers who smoke, or
medical care costs associated with diseases caused by second hand smoke.
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